CW
VRTX icon

CreativeOne Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

CreativeOne Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$859K Sell
1,924
-166
-8% -$77.4K 0.02% 632
2025
Q4 		$948K Sell
2,090
-220
-10% -$94.8K 0.02% 573
2025
Q3 		$905K Sell
2,310
-2,723
-54% -$1.14M 0.02% 583
2025
Q2 		$2.24M Sell
5,033
-950
-16% -$438K 0.06% 313
2025
Q1 		$2.9M Buy
5,983
+628
+12% +$293K 0.09% 220
2024
Q4 		$2.16M Sell
5,355
-2,120
-28% -$983K 0.07% 275
2024
Q3 		$3.48M Buy
7,475
+3,242
+77% +$1.56M 0.12% 164
2024
Q2 		$1.98M Sell
4,233
-1,217
-22% -$528K 0.1% 198
2024
Q1 		$2.28M Buy
+5,450
New +$2.3M 0.09% 209
2023
Q3 		– Sell
-2,647
Closed -$932K – 825
2023
Q2 		$932K Sell
2,647
-323
-11% -$109K 0.04% 346
2023
Q1 		$936K Buy
2,970
+169
+6% +$50.7K 0.05% 319
2022
Q4 		$809K Sell
2,801
-304
-10% -$92.7K 0.04% 324
2022
Q3 		$899K Buy
3,105
+2,297
+284% +$661K 0.05% 282
2022
Q2 		$228K Sell
808
-31
-4% -$8.3K 0.01% 639
2022
Q1 		$219K Buy
+839
New +$199K 0.01% 676

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CreativeOne Wealth's VRTX Position: Q1 2026 in Review

CreativeOne Wealth reduced its Vertex Pharmaceuticals (VRTX) stake by 7.9% in Q1 2026, selling an estimated $77.4K and leaving 1,924 shares worth $859K. The position accounts for 0.02% of the portfolio, ranked #632.

CreativeOne Wealth first reported a position in VRTX in Q1 2022 and has held it in 15 quarters since. The position peaked at $3.48M in Q3 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • CreativeOne Wealth held 1,924 shares of Vertex Pharmaceuticals worth $859K as of Q1 2026.
  • CreativeOne Wealth sold 166 Vertex Pharmaceuticals shares in Q1 2026, an estimated $77.4K.
  • Vertex Pharmaceuticals made up 0.02% of CreativeOne Wealth's portfolio in Q1 2026, its #632 holding.
  • CreativeOne Wealth first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 15 quarters since.
  • CreativeOne Wealth's Vertex Pharmaceuticals position peaked at $3.48M in Q3 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.